The retailer is expected to remain under pressure from flagging demand for home improvement.

Doughnut chain Krispy Kreme (NASDAQ:DNUT) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 10.4% year on year to $404 million. The company’s full-year revenue guidance of $1.6 billion at the midpoint came in 10.4% below analysts’ estimates. Its non-GAAP profit of $0.01 per share was 89.8% below analysts’ consensus estimates.

Dogecoin's recent decline has analysts sounding the alarm, with Ali Martinez—who once predicted a $4 DOGE — now warning that a drop to $0.20 is possible.

The tech-heavy Nasdaq led Wall Street declines on Tuesday, hitting a six-week low after fresh economic data indicated a deterioration in consumer sentiment and investors braced for the potential impact of tighter U.S. trade curbs on Beijing. A Conference Board report showed an index tracking consumer confidence stood at 98.3 in February compared with an estimate of 102.5, according to economists polled by Reuters. Investors also focused on a report that said the U.S. was planning further restrictions on Nvidia's chip exports to China and that Washington was consulting with allies about tightening chip controls on China.

(Bloomberg) -- A widely-watched gauge of the attractiveness of German debt fell to the most negative on record as policymakers discuss borrowing more to fund defense spending.Most Read from BloombergTrump Targets $128 Billion California High-Speed Rail ProjectTrump Asserts Power Over NYC, Proclaims ‘Long Live the King’NYC’s Congestion Pricing Pulls In $48.6 Million in First MonthNYC to Shut Migrant Center in Former Hotel as Crisis EasesAs Visitors Discover Ghent, the City Is Trying to Prevent a

Children’s apparel manufacturer Carter’s (NYSE:CRI) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, but sales were flat year on year at $859.7 million. On the other hand, next quarter’s revenue guidance of $620 million was less impressive, coming in 5.3% below analysts’ estimates. Its non-GAAP profit of $2.39 per share was 24.6% above analysts’ consensus estimates.

Dental and medical products company Henry Schein (NASDAQ:HSIC) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 5.8% year on year to $3.19 billion. Its non-GAAP profit of $1.19 per share was 1.6% below analysts’ consensus estimates.

(Bloomberg) -- There’s growing “suspicion” among investors about the scope for more S&P 500 gains at a time when European and Chinese stocks are outperforming, according to Bank of America Corp. strategist Michael Hartnett.Most Read from BloombergTrump Targets $128 Billion California High-Speed Rail ProjectTrump Asserts Power Over NYC, Proclaims ‘Long Live the King’NYC’s Congestion Pricing Pulls In $48.6 Million in First MonthNYC to Shut Migrant Center in Former Hotel as Crisis EasesAs Visitors

Medical device company Integra LifeSciences (NASDAQ:IART) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 11.5% year on year to $442.6 million. Next quarter’s revenue guidance of $380 million underwhelmed, coming in 7.7% below analysts’ estimates. Its non-GAAP profit of $0.97 per share was 13.5% above analysts’ consensus estimates.